1-2 of 2
Pierre Delobel
Close
Sort by
Journal Articles

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Paul G. Rubinstein, MD, Page C. Moore, PhD, Milan Bimali, PhD, Amy Chadburn, MD, Ethel Cesarman, MD PhD, Michelle Rudek, PharmD, PhD, Lee Ratner, MD PhD, Richard F. Ambinder, MD, David H. Henry, MD, Stefan K. Barta, MD MRCP, MS, Herve Ghesquieres, MD PhD, Paul Coppo, MD PhD, Pierre Delobel, MD, Francois Boue, MD PhD, Lionel Galicier, MD, Juan Carlos Ramos, MD BS, Erin G. Reid, MD MS, Elad Sharon, MD MPH, Nicolas Mounier, MD, Caroline Besson, MD PhD, Ariela Noy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 130.
https://doi.org/10.1182/blood-2019-126787
Published: 2019
Journal Articles

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Caroline Besson, MDPhD, Nicolas Noel, Remi Lancar, Sophie Prevot, Michele Algarte-Genin, Rosenthal Eric, Fabrice Bonnet, Marie-Caroline Meyohas, Marialuisa Partisani, Lucie Oberic, MD, Jean Gabarre, Cecile Goujard, Antoine Cheret, Cedric Arvieux, Bertrand Coiffier, MD PhD, Christine Katlama, Dominique Salmon, Francois Boue, MD PhD, Regis T. Costello, MD, Nawel Mekerri, Houria Hendel-Chavez, Yassine Taoufik, Helene Fontaine, Paul Coppo, MD PhD, Nicolas Mounier, Pierre Delobel, Dominique Costagliola
Journal: Blood
Blood (2017) 130 (Supplement 1): 1003.
https://doi.org/10.1182/blood.V130.Suppl_1.1003.1003
Published: 2017